Medibank Shares (MPL ASX) has been a good performer since the IPO and if we compare ASX MPL vs NHF, it has single handedly outperform its nearest competitor.
When the Australian government sold Medibank it was primarily targeted and sold to mom and dad investors as a safe blue chip company and the results speak for itself as it delivered consistent income with share price maintaining capital preservation since.
We consider Australia private health insurance sector an oligopolistic structure where few players dominate the industry. The 2 largest private health insurance providers in Australia are listed, ASX MPL and ASX NHF (NIB Healthcare). The third largest player, BUPA is a privately owned UK company.
ASX MPL vs NHF
The last 12 month share price shows MPL handily outperformed NHF.
[wpdatatable id=253]
MPL dividend yield shows it trades broadly inline with market average and the market cap size mean it is included in the S&P/ASX 50 index.
Medibank Private Quality
We can invest across the globe in search of great companies at decent prices. Quality Australian companies in the All Ordinary index usually trades at a premium as the market is always short of quality stock outside of the mining and financial sectors and Australia super funds have been perennially overweight equities.
Only because a company is well run and attractively positioned in the industry does not necessarily mean it would be a good investment. Medibank trades at a premium to the rest of the market due to the simple fact there is a darth of defensive stocks listed on the ASX.
MPL Dividend History
[wpdatatable id=252]
MPL dividend dates are in September for final dividend and March for interim dividends.